Vision

The number of men dying from prostate cancer has overtaken the number of deaths from breast cancer.

At present, there is no screening test that is routinely offered to all men who might be at risk. Women are offered screening for breast cancer with regular mammograms.

Prostate cancer is the most common cancer in men and there is a need for an accurate test which could be offered to all men to check for prostate cancer.

There is a blood test called prostate-specific antigen (PSA) but it is too unreliable.

As a result, prostate cancer screening is not recommended in any country. We need a better test that is more accurate.

Initiatives

"Being diagnosed with prostate cancer picked up by the MRI was a bit of a shock. I had some prostate issues about 7 years ago and had a PSA test and everything was fine. If I hadn’t taken part in the trial and just gone to my doctor I would have accepted that my PSA was still completely normal. Now if someone asked me, I’d say to request an MRI scan because the PSA is useful but it does have weaknesses. My surgeon and I decided prostatectomy would be the best course of action for treatment. The cancer was completely removed and I was back at work quickly."

Mark, 62, was diagnoised with prostate cancer after having a PROSTAGRAM following a normal PSA test.

MRI is currently only offered to men who request and then have an abnormal PSA blood test and are seen in hospital. This follows a decade of research, which we have led on, that confirmed that MRI is an accurate method of diagnosing prostate cancer.

PROSTAGRAM could allow all men to be offered a fast MRI in the community. The aim for this to be the first reliable method for identifying dangerous tumours in the general population.

Details For Supporters

We want to roll out the PROSTAGRAM across the country and test it on a larger scale.

The Imperial Prostate Foundation has launched a £2 million fund raising campaign to set up prostate cancer screening using PROSTAGRAMS that can operate from anywhere including such places as supermarket car parks.

The aim is to encourage more men to be screened for prostate cancer including hard-to-reach groups and those living in rural or difficult to reach areas.

The programme of research has already received generous support from the Wellcome Trust, The Urology Foundation, British Medical Association and Royal College of Surgeons of England.